A device smaller than a quarter is giving heart patients a new lease on life. The Watchman device is implanted in the heart to prevent blood clots from forming without the need of blood thinners. This ...

ROCHESTER, MN – The PREVAIL study, a clinical trial evaluating the safety of the Watchman (Boston Scientific) left atrial appendage (LAA) closure device in the treatment of patients with nonvalvular ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Rates of patency and device-related thrombus were ...

McLaren Northern Michigan performed 75 transcatheter aortic valve replacement procedures in 2025, more than double the ...

MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning ...

There are hundreds of people who will be around to celebrate 2024 thanks to a little-known device called the WATCHMAN. “I think we’re actually at 250 for the program and at least 20 more procedures ...

The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally invasive solution for ...

ZANESVILLE – Genesis HealthCare System’s Heart and Vascular team recently performed the 300th WATCHMAN Implant procedure. The WATCHMAN Implant is completed through a minimally invasive procedure and ...

LAKE CHARLES, La. (KPLC) - A big milestone happened over at CHRISTUS Ochsner St. Patrick Hospital this week. Their cardiology team announced they have implanted 500 Watchman devices for patients with ...

The Watchman left atrial appendage (LAA) closure device (Boston Scientific) is associated with low 1-year stroke rates, despite being used commercially in older, sicker patients than seen in pivotal ...

Left atrial appendage (LAA) occlusion procedures are designed to reduce the risk of thromboembolism in patients who have non-valvular atrial fibrillation, but a study presented at the 2023 ...